In the HCC tumor microenvironment, PDCD1 is expressed in CD8+ T cells, and when activated, PDCD1 inhibits T cell migration, proliferation and secretion of cytotoxic mediators, thereby blocking the “cancer immune cycle” (35). Here, PDCD1 is linked to neoplasm.